1.
Goričar K, Kovač V, Dolžan V. The influence of folate pathway polymorphisms on pemetrexed treatment outcome in patients with malignant mesothelioma. Radiol Oncol [Internet]. 2014 May 9 [cited 2026 Jun. 10];48(2). Available from: https://radioloncol.com/index.php/ro/article/view/2043